Max Mousseron Biomolecules Institute (IBMM)
The IBMM conducts research on biomolecules (lipids, sugars, proteins, and DNA/RNA), which are the building blocks of life. This research, at the interface between chemistry and biology, contributes to a better understanding of physiological and pathophysiological mechanisms and to the development of innovative tools for healthcare: new, more effective treatments (for cancer, cardiovascular disease, neurodegenerative diseases), new medical devices, new cosmetic approaches, and new diagnostic systems.
The IBMM teams' areas of expertise include:
- the design through molecular modeling and synthesis of biomolecules and derivatives using more efficient methods that preserve the environment;
- the development of analytical methods for characterizing biomolecules and their analysis in biological environments;
- in vitro pharmacological, toxicological, and biological studies of these biomolecules to validate their properties and select the most promising ones for development into new therapeutic and diagnostic systems and devices;
- IBMM's expertise makes it a unique laboratory for promoting its research, which has led to the launch of two drugs (Macrilen, Sébivo) and the creation of several companies.
Immersion in the IBMM provides a unique educational experience for students who wish to tackle the challenges of the future in the field of life sciences.
Label:Joint Research Unit Research UMR)
Main supervisory bodies: CNRS, UM, ENSCM
Research cluster:Chemistry
Doctoral schools:Chemical Sciences BALARD;Chemical and Biological Sciences for Health
HAL portal: publications by the organization
